Recombinant human interferon alpha-2b (Shenzhen Neptunus)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant human interferon alpha-2b (Shenzhen Neptunus)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsHepatitisNeoplasmsHerpes Zoster +[4] 
Global Approved IndicationsHepatitisNeoplasmsHerpes Zoster +[4] 
Approved Indications in ChinaHepatitisNeoplasmsHerpes Zoster +[4] 
Original Approved Country/TerritoryMainland China
Original Approved Date2012/02/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShenzhen Neptunus Interlong Bio-Technique Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Neptunus Interlong Bio-Technique Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitisNeoplasmsHerpes Zoster +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeL03AB05
Related LinksN/A